UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 65 filers reported holding UNITY BIOTECHNOLOGY INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $124,000 | +14.8% | 20,651 | +0.3% | 0.00% | – |
| Q4 2020 | $108,000 | +50.0% | 20,596 | -1.2% | 0.00% | – |
| Q3 2020 | $72,000 | -58.9% | 20,838 | +3.5% | 0.00% | -100.0% |
| Q2 2020 | $175,000 | +78.6% | 20,125 | +19.0% | 0.00% | 0.0% |
| Q1 2020 | $98,000 | -24.0% | 16,916 | -5.5% | 0.00% | – |
| Q4 2019 | $129,000 | +25.2% | 17,894 | +6.2% | 0.00% | – |
| Q3 2019 | $103,000 | -36.0% | 16,853 | -0.7% | 0.00% | -100.0% |
| Q2 2019 | $161,000 | +24.8% | 16,970 | +6.9% | 0.00% | – |
| Q1 2019 | $129,000 | -51.5% | 15,871 | -3.1% | 0.00% | -100.0% |
| Q4 2018 | $266,000 | +383.6% | 16,386 | +389.4% | 0.00% | – |
| Q3 2018 | $55,000 | +10.0% | 3,348 | +1.8% | 0.00% | – |
| Q2 2018 | $50,000 | – | 3,288 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 1,571,981 | $7,294,000 | 8.07% |
| Invus Financial Advisors, LLC | 1,094,998 | $5,081,000 | 1.01% |
| Founders Fund V Management, LLC | 491,751 | $2,282,000 | 0.78% |
| Tibra Equities Europe Ltd | 80,700 | $374,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 205,882 | $955,000 | 0.11% |
| Hall Private Wealth Advisors | 18,500 | $86,000 | 0.06% |
| 20/20 Capital Management, Inc. | 42,840 | $199,000 | 0.05% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 64,789 | $301,000 | 0.05% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 759,918 | $3,526,000 | 0.02% |
| PDT Partners, LLC | 74,178 | $344,000 | 0.02% |